Funded Tech Companies
Tasca Therapeutics
Tasca Therapeutics, operating out of Boston, received equity investments through Regeneron Pharmaceuticals and Invus.
Company Overview
Company Name
Tasca Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
349 Newbury Street, 2nd Floor
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
By harnessing the power of mass spectrometry-based proteomics to identify cancer-causing proteins that undergo a specific post-translational modification called auto-palmitoylation, Tasca is uniquely positioned to utilize previously unknown binding pockets to develop novel therapies for difficult-to-treat cancers. Tasca's lead program, CP-383, is being developed to treat patients with tumors harboring a specific genetic profile and is expected to enter clinical trials in 2025.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/10/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Milenko Cicmil
Co-Founder
David Fisher
Co-Founder
Xu Wu
Company Investors
- Regeneron Pharmaceuticals
- Invus
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs